38 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
milestones or developments; market share; economic value or economic value added models; division, group or corporate financial goals; customer … satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company
8-K
EX-10.1
GOSS
Gossamer Bio Inc
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
, manufacturer, customer or contractor of the Company or any of its subsidiaries, exists or, to the Company’s Knowledge, is threatened or imminent. No executive
8-K
EX-1.1
njky55irrqp7l364
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
v2z 0dvmzmt
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
85k tiiamcl6
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
b14icupdhn
18 May 20
Prospectus supplement for primary offering
4:16pm
8-K
EX-10.1
9gv03
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
10-K
t0b04vk8mm
22 Mar 19
Annual report
4:45pm
424B4
vw7tmhi4d
8 Feb 19
Prospectus supplement with pricing info
4:40pm